China Has Administered More Than 9 Million Vaccine Doses
(Bloomberg) --
China has administered more than 9 million anti-coronavirus vaccine doses as the country braces for a possible increase in infections during the winter.
Some 7.5 million doses have been given since Dec. 15, officials told a briefing in Beijing. Vaccines are free for all citizens and the costs will be covered by the medicare fund and fiscal budgets, they said.
China sees a bigger risk of the virus spreading in winter as people travel and gather for holidays, National Health Commission Deputy Head Zeng Yixin told reporters.
The vaccination roll-out is focused first on high-risk population groups because production capacity can't keep up, Zeng said. Capacity is steadily ramping up now and it will enable administration of doses to the general public, he said, without giving a timeline.
China is “active, open and supportive” of a visit to Wuhan by the World Health Organization to probe the origins of the virus, Zeng said. China has lined up its own experts to work with WHO experts in Wuhan. The timing of the WHO team's arrival in China is still being confirmed, he said.
©2021 Bloomberg L.P.
With assistance from Bloomberg
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.